Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4Sarcoma 3Thoracic 2Gynecologic 2Genitourinary 2Dermatologic 2Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Lymphoma, Non-Hodgkin 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Mantle-Cell 12Lymphoma, Large B-Cell, Diffuse 12Lymphoma, Follicular 12Lymphoma 12Leukemia, Lymphocytic, Chronic, B-Cell 12Lymphoma, Large-Cell, Immunoblastic 11Burkitt Lymphoma 11Lymphoma, B-Cell, Marginal Zone 10Hodgkin Disease 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia 5Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myeloid, Acute 4Immunoblastic Lymphadenopathy 4Ovarian Neoplasms 3Breast Neoplasms 3Waldenstrom Macroglobulinemia 2Triple Negative Breast Neoplasms 2Sezary Syndrome 2Sarcoma 2Pancreatic Neoplasms 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lung Neoplasms 2Kidney Neoplasms 2Intraocular Lymphoma 2Hematologic Neoplasms 2Glioma 2

Interventions

Psychiatric Rehabilitation 2Drug Therapy 2sargramostim 1romidepsin 1ixabepilone 1entinostat 1carboxyamido-triazole 1Topotecan 1Thalidomide 1Temozolomide 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1O(6)-benzylguanine 1N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine 1Molecular Diagnostic Techniques 1Megestrol Acetate 1Immunotherapy 1Gelclair 1Filgrastim 1Fentanyl 1Docetaxel 1Dexamethasone 1Cyproheptadine 1Carmustine 1Calcium Dobesilate 1Busulfan 1Biological Therapy 1Amplified Fragment Length Polymorphism Analysis 190Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Astrocytoma × Paclitaxel × Other hematologic neoplasm × Clear all
NCT00019019 2012-03-15

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
70 enrolled
BreastCNSDermatologicGenitourinaryGynecologicLymphoidOther hematologic neoplasmSarcomaThoracic

Carcinoma, Ovarian Epithelial, Astrocytoma, Brain Neoplasms, Breast Neoplasms, Burkitt Lymphoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Medulloblastoma, Melanoma, Meningioma, Mycosis Fungoides, Oligodendroglioma, Ovarian Neoplasms, Pinealoma, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Lymphoma, Large-Cell, Anaplastic, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡